These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31001265)

  • 21. CD99 plays a major role in the migration of monocytes through endothelial junctions.
    Schenkel AR; Mamdouh Z; Chen X; Liebman RM; Muller WA
    Nat Immunol; 2002 Feb; 3(2):143-50. PubMed ID: 11812991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mouse CD99 participates in T-cell recruitment into inflamed skin.
    Bixel G; Kloep S; Butz S; Petri B; Engelhardt B; Vestweber D
    Blood; 2004 Nov; 104(10):3205-13. PubMed ID: 15280198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthetic siRNA targeting the breakpoint of EWS/Fli-1 inhibits growth of Ewing sarcoma xenografts in a mouse model.
    Takigami I; Ohno T; Kitade Y; Hara A; Nagano A; Kawai G; Saitou M; Matsuhashi A; Yamada K; Shimizu K
    Int J Cancer; 2011 Jan; 128(1):216-26. PubMed ID: 20648560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD99 triggering in Ewing sarcoma delivers a lethal signal through p53 pathway reactivation and cooperates with doxorubicin.
    Guerzoni C; Fiori V; Terracciano M; Manara MC; Moricoli D; Pasello M; Sciandra M; Nicoletti G; Gellini M; Dominici S; Chiodoni C; Fornasari PM; Lollini PL; Colombo MP; Picci P; Cianfriglia M; Magnani M; Scotlandi K
    Clin Cancer Res; 2015 Jan; 21(1):146-56. PubMed ID: 25501132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ewing's sarcoma--routine diagnostic utilization of MIC2 analysis: a Pediatric Oncology Group/Children's Cancer Group Intergroup Study.
    Perlman EJ; Dickman PS; Askin FB; Grier HE; Miser JS; Link MP
    Hum Pathol; 1994 Mar; 25(3):304-7. PubMed ID: 8150461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MIC2 detection in tumors of bone and adjacent soft tissues.
    Devaney K; Abbondanzo SL; Shekitka KM; Wolov RB; Sweet DE
    Clin Orthop Relat Res; 1995 Jan; (310):176-87. PubMed ID: 7641436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting CD99 in association with doxorubicin: an effective combined treatment for Ewing's sarcoma.
    Scotlandi K; Perdichizzi S; Bernard G; Nicoletti G; Nanni P; Lollini PL; Curti A; Manara MC; Benini S; Bernard A; Picci P
    Eur J Cancer; 2006 Jan; 42(1):91-6. PubMed ID: 16326096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preclinical evidence that use of TRAIL in Ewing's sarcoma and osteosarcoma therapy inhibits tumor growth, prevents osteolysis, and increases animal survival.
    Picarda G; Lamoureux F; Geffroy L; Delepine P; Montier T; Laud K; Tirode F; Delattre O; Heymann D; Rédini F
    Clin Cancer Res; 2010 Apr; 16(8):2363-74. PubMed ID: 20371692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extraskeletal Ewing's sarcoma of the nose.
    Böör A; Jurkovic I; Friedmann I; Plank L; Kocan P
    J Laryngol Otol; 2001 Jan; 115(1):74-6. PubMed ID: 11233634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. EWS/FLI-l peptide-pulsed dendritic cells induces the antitumor immunity in a murine Ewing's sarcoma cell model.
    Peng W; Huang X; Yang D
    Int Immunopharmacol; 2014 Aug; 21(2):336-41. PubMed ID: 24861249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell Adhesion Molecule CD99 in Cancer Immunotherapy.
    Yu F; Liu G; Zhang H; Wang X; Wu Z; Xu Q; Wu Y; Chen D
    Curr Mol Med; 2023; 23(10):1028-1036. PubMed ID: 36214301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EWS/Fli-1 chimeric fusion gene upregulates vascular endothelial growth factor-A.
    Nagano A; Ohno T; Shimizu K; Hara A; Yamamoto T; Kawai G; Saitou M; Takigami I; Matsuhashi A; Yamada K; Takei Y
    Int J Cancer; 2010 Jun; 126(12):2790-8. PubMed ID: 19642105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peripheral primitive neuroectodermal tumor of the ovary confirmed by CD99 immunostaining, karyotypic analysis, and RT-PCR for EWS/FLI-1 chimeric mRNA.
    Kawauchi S; Fukuda T; Miyamoto S; Yoshioka J; Shirahama S; Saito T; Tsukamoto N
    Am J Surg Pathol; 1998 Nov; 22(11):1417-22. PubMed ID: 9808135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clofarabine inhibits Ewing sarcoma growth through a novel molecular mechanism involving direct binding to CD99.
    Çelik H; Sciandra M; Flashner B; Gelmez E; Kayraklıoğlu N; Allegakoen DV; Petro JR; Conn EJ; Hour S; Han J; Oktay L; Tiwari PB; Hayran M; Harris BT; Manara MC; Toretsky JA; Scotlandi K; Üren A
    Oncogene; 2018 Apr; 37(16):2181-2196. PubMed ID: 29382926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Esophageal extraskeletal Ewing's sarcoma.
    Maesawa C; Iijima S; Sato N; Yoshinori N; Suzuki M; Tarusawa M; Ishida K; Tamura G; Saito K; Masuda T
    Hum Pathol; 2002 Jan; 33(1):130-2. PubMed ID: 11823984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MIC2 is a specific marker for Ewing's sarcoma and peripheral primitive neuroectodermal tumors. Evidence for a common histogenesis of Ewing's sarcoma and peripheral primitive neuroectodermal tumors from MIC2 expression and specific chromosome aberration.
    Ambros IM; Ambros PF; Strehl S; Kovar H; Gadner H; Salzer-Kuntschik M
    Cancer; 1991 Apr; 67(7):1886-93. PubMed ID: 1848471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clofarabine induces ERK/MSK/CREB activation through inhibiting CD99 on Ewing sarcoma cells.
    Sevim H; Çelik H; Düşünceli L; Ceyhan CS; Molotkova A; Nakazawa K; Graham GT; Petro JR; Toretsky JA; Üren A
    PLoS One; 2021; 16(6):e0253170. PubMed ID: 34133426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-CD99 scFv-ELP nanoworms for the treatment of acute myeloid leukemia.
    Vaikari VP; Park M; Keossayan L; MacKay JA; Alachkar H
    Nanomedicine; 2020 Oct; 29():102236. PubMed ID: 32535112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic utility of FLI-1 monoclonal antibody and dual-colour, break-apart probe fluorescence in situ (FISH) analysis in Ewing's sarcoma/primitive neuroectodermal tumour (EWS/PNET). A comparative study with CD99 and FLI-1 polyclonal antibodies.
    Mhawech-Fauceglia P; Herrmann F; Penetrante R; Beck A; Sait S; Block AM; Odunsi K; Fisher J; Balos L; Cheney RT
    Histopathology; 2006 Dec; 49(6):569-75. PubMed ID: 17163841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Triggering of CD99 on monocytes by a specific monoclonal antibody regulates T cell activation.
    Laopajon W; Pata S; Takheaw N; Surinkaew S; Khummuang S; Kasinrerk W
    Cell Immunol; 2019 Jan; 335():51-58. PubMed ID: 30396687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.